N-acetylcysteine treatment blocks the development of ethanol-induced behavioural sensitization and related Delta FosB alterations

Author(s)

Morais-Silva, Gessynger ; Alves, Gabrielle Cunha ; Marin, Marcelo T.

• Document type: Journal article
• Source: Neuropharmacology; v. 110, n. A, p. 135-142, NOV 2016.
• Web of Science Citations: 6

Abstract

Ethanol addiction is a serious public health problem that still needs more effective pharmacological treatment. A key factor in the development and maintenance of this disease is the advent of neuroadaptations in the mesocorticolimbic brain pathway upon chronic ethanol abuse. In general, these neuroadaptations are maladaptive and affect numerous neurotransmitter systems and intracellular molecules. One of these molecules is AFosB, a transcription factor that is altered after chronic drug use. Behavioural sensitization is a useful model for the study of the neuroadaptations related to addiction. Recent works have shown a role for the imbalance of glutamatergic neurotransmission in the symptoms found in addicted people. In this sense, the treatment with N-acetylcysteine, a L-cysteine prodrug that acts by restoring extrasynaptic concentrations of glutamate through the activation of cystine-glutamate antiporter, has shown promising results in the treatment of addiction. Thus, an animal model of behavioural sensitization was used to evaluate the effects of N-acetylcysteine treatment in the behavioural and molecular alterations induced by chronic ethanol administration. Swiss mice were subject to 13 days of daily ethanol administration to induce behavioural sensitization. Two hours before each ethanol administration and locomotor activity evaluation, the animals received intraperitoneally N-acetylcysteine injections. Immediately after the last test session, their brains were removed for Delta FosB and cystine-glutamate antiporter quantification. It was found that N-acetylcysteine treatment blocked ethanol-induced behavioural sensitization, the increase of Delta FosB content in the prefrontal cortex, and its reduction in the nucleus accumbens. The results suggest a possible use of N-acetylcysteine in ethanol related disorders. (C) 2016 Elsevier Ltd. All rights reserved. (AU)

• FAPESP's process: 14/02371-9 - Neuroadaptations and behavioral alterations related to ethanol addiction: effects of N-acetylcysteine treatment in mice
• Grantee: Marcelo Tadeu Marin
• Support type: Regular Research Grants
• FAPESP's process: 15/01026-9 - Behavioral sensitization and ethanol-induced neuroadaptations: effects of N-acetylcysteine treatment in mice
• Grantee: Gessynger Morais Silva
• Support type: Scholarships in Brazil - Master